secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2024-06-27T23:59:59+00:00
Accession:  0001683168-24-004506
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals files prospectus supplement for ATM equity facility
--------------------------------------------------------------------------

- Filed a prospectus supplement on June 27, 2024 for at-the-market offering of common stock through Maxim Group LLC.
- Agreement originally dated Dec 15, 2023, and amended March 8, 2024; no changes to terms disclosed.
- Polsinelli PC legal opinion on share validity filed as Exhibit 5.1.
- No sales amounts or proceeds reported; facility remains available for use.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824004506/0001683168-24-004506-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316824004506/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-004506

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer